Last reviewed · How we verify
Inactivated, split-virion influenza virus
Stimulates an immune response against influenza virus
Stimulates an immune response against influenza virus Used for Influenza prevention.
At a glance
| Generic name | Inactivated, split-virion influenza virus |
|---|---|
| Also known as | Vaxigrip®, Fluzone® |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Drug class | Influenza vaccine |
| Modality | Biologic |
| Therapeutic area | Infectious Disease |
| Phase | Phase 2 |
Mechanism of action
This inactivated, split-virion influenza virus vaccine works by exposing the body's immune system to a small, harmless piece of the influenza virus, prompting the body to produce antibodies that can fight the flu.
Approved indications
- Influenza prevention
Common side effects
- Pain, redness, or swelling at the injection site
- Fatigue
- Headache
Key clinical trials
- Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children . (PHASE3)
- Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older (PHASE3)
- Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine (PHASE3)
- A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine (PHASE2)
- Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais (PHASE1, PHASE2)
- Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (PHASE3)
- Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split Vaccine (PHASE3)
- Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: